Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PPCC 02

X
Drug Profile

PPCC 02

Alternative Names: PPCC-02

Latest Information Update: 03 Oct 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Immorta Bio
  • Class Cell therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Research Heart failure

Most Recent Events

  • 11 Sep 2024 PPCC 02 is available for licensing as of 11 Sep 2024. https://www.immortabio.com/#collaboration (Immorta Bio pipeline, September 2024)
  • 11 Sep 2024 Early research in Heart failure in USA (Parenteral) prior to September2024 (Immorta Bio pipeline, September 2024)
  • 30 Nov 2023 Immorta Bio has patent pending for the treatment of heart failure using pluripotent stem cell derived cardiomyocytes in an Unknown location (Immorta Bio website, September 2024)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top